Literature DB >> 3260778

Inhibition of cartilage proteoglycan synthesis by interleukin I.

H P Benton1, J A Tyler.   

Abstract

We have investigated the mechanism of inhibition of cartilage proteoglycan by interleukin 1. Proteoglycan synthesis was inhibited using lower doses of interleukin 1 than those required to cause cartilage resorption. There was no significant effect on DNA or total protein synthesis. Gel electrophoresis showed a direct inhibitory effect on core protein synthesis while pulse-chase experiments using radiolabelled sulphate showed no alteration in the rate of intracellular transport and secretion of completed proteoglycan. Chondrocytes incubated with cycloheximide showed a first-order decrease in rate of uptake of radiolabelled sulphate (t1/2 = 25 mins) but interleukin 1 induced inhibition showed a delay of at least 1 hr, consistent with a requirement to deplete intracellular pools of protein before effects on post-translational events could be observed. Foetal and neonatal cartilage responded to the cytokine in a similar way to adult cartilage.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260778     DOI: 10.1016/0006-291x(88)90703-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

1.  Sorbitol-modified hyaluronic acid reduces oxidative stress, apoptosis and mediators of inflammation and catabolism in human osteoarthritic chondrocytes.

Authors:  John-Max Mongkhon; Maryane Thach; Qin Shi; Julio C Fernandes; Hassan Fahmi; Mohamed Benderdour
Journal:  Inflamm Res       Date:  2014-05-25       Impact factor: 4.575

2.  N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures. Putative site(s) of enzymic cleavage.

Authors:  P Loulakis; A Shrikhande; G Davis; C A Maniglia
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

3.  Beneficial effects of cerium oxide nanoparticles in development of chondrocyte-seeded hydrogel constructs and cellular response to interleukin insults.

Authors:  Sathish Ponnurangam; Grace D O'Connell; Irina V Chernyshova; Katherine Wood; Clark Tung-Hui Hung; Ponisseril Somasundaran
Journal:  Tissue Eng Part A       Date:  2014-06-25       Impact factor: 3.845

4.  Interleukin 1-induced calcium signalling in chondrocytes requires focal adhesions.

Authors:  L Luo; T Cruz; C McCulloch
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

Review 5.  Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes.

Authors:  P J Verschure; C J Van Noorden; J Van Marle; W B Van den Berg
Journal:  Histochem J       Date:  1996-12

Review 6.  Emerging technologies for molecular therapy for intervertebral disk degeneration.

Authors:  Won C Bae; Koichi Masuda
Journal:  Orthop Clin North Am       Date:  2011-10       Impact factor: 2.472

7.  Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines.

Authors:  J A Tyler
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

8.  Differential effects of interleukin-1 and transforming growth factor beta on the synthesis of small proteoglycans by rabbit articular chondrocytes cultured in alginate beads as compared to monolayers.

Authors:  M Demoor-Fossard; M Boittin; F Redini; J P Pujol
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

9.  Comparison of mobility changes with histological and biochemical changes during lipopolysaccharide-induced arthritis in the hamster.

Authors:  I G Otterness; M L Bliven; A J Milici; A R Poole
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

10.  Insulin-like growth factor I accelerates recovery of articular cartilage proteoglycan synthesis in culture after inhibition by interleukin 1.

Authors:  J Neidel; M Schulze; L Sova
Journal:  Arch Orthop Trauma Surg       Date:  1994       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.